Voyager Therapeutics, Inc. Banner Image

Voyager Therapeutics, Inc.

  • Ticker VYGR
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Voyager Therapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in Cambridge, Massachusetts
Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases. Voyager is committed to advancing the field of AAV gene therapy through innovation and investment in vector engineering and optimization, manufacturing, and dosing and delivery techniques. Voyager’s wholly owned and partnered pipeline focuses onMore severe neurological diseases for which effective new therapies are needed, including Parkinson’s disease, Huntington’s disease, Friedreich’s ataxia, and other severe neurological diseases.
4.8 / 5.0 (150)

Voyager Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 150 reviews.

Voyager Therapeutics, Inc.

Most Recent Annual Report

Voyager Therapeutics, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Voyager Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!